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Adipose tissueGhrelin is a hormone synthesized by the stomach that acts in different tissues via a speciﬁc receptor
(GHS-R1a), including hypothalamus and adipose tissue. For instance, recent reports have shown that ghrelin
has a direct action on hypothalamic regulation of food intake mainly inducing an orexigenic effect. On the
other hand, ghrelin also modulates energy stores and expenditure in the adipocytes. This dual action has
suggested that this hormonemay act as a link between the central nervous system and peripheral mechanisms.
Furthermore, concerning nutritional disorders, it has been suggested that obesity may be considered an
impairment of the above cited link. Therefore, considering that neonatal overfeeding induces obesity in
adulthood by unknown mechanisms, in this study we examined the effects of early life overnutrition on
the development of obesity and in particular on adipose tissue ghrelin signaling in young mice. Our data
demonstrated that overnutrition during early life induces a signiﬁcant increase in body weight of young
mice, starting at 10 days, and this increase in weight persisted until adulthood (90 days of age). In these
animals, blood glucose, liver weight and visceral fat weight were found higher at 21 days when compared to
the control group. Acylated ghrelin circulating levels were found lower in the young obese pups. In addition,
in white adipose tissue ghrelin receptor (GHS-R1a) expression increased and was associated to positive
modulation of content and phosphorylation of proteins involved in cell energy store and use as AKT, PI3K,
AMPK, GLUT-4, and CPT1. However, PPARγ content decreased in obese group. Basically, we showed
that adipose tissue metabolism is altered in early life acquired obesity and probably due to such modiﬁcation
a new pattern of ghrelin signaling pathway takes place.
© 2011 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
The World Health Organization (WHO) estimates that by 2015
approximately 2.3 billion adults will be overweight and more than
700 million will be obese [1]. Obesity has been described as a condition
that results from chronic disruption of energy balance; like so, energy
intake continuously exceeds energy expenditure and accumulation of
body fat occurs [2]. Expansion of white adipose tissue (WAT) volume
from either increased adipocyte number (adipogenesis) and/or
increased adipocyte size resulted from enhanced substrate uptake,
elevated lipid synthesis (lipogenesis), decreased lipid utilization
(lipolysis), and/or reduced lipid export, which are central in energy
metabolism regulation. Also, adipocytes, by releasing the stored
free fatty acids, are able to modulate glucose uptake in muscle, insulin
secretion by pancreatic β cells and increase the production of glucose
in the liver [3–7].
It has been shown recently that obesity is increasing at younger
ages. Along these lines, it has been reported that overnutrition during: +55 21 2587 6129.
vier OA license. critical period of development, as lactation, represents a risk factor for
later obesity [1,8]. For instance, in humans it has been described that
weight gain in the ﬁrst 6 months after birth is associatedwith obesity at
ages 6 to 8 years [9]. Therefore the impact of early obesity is associated
with other diseases. As widely demonstrated, weight gain during
childhood results in cardiovascular diseases and type 2 diabetes (T2D)
in adulthood [6,7,10]. The phenomenon and associations described
above have also been observed in experimental animal models. Like
so, Plagemann and coworkers observed similar behavior in neonatal
overfed rats raised in small litters (SL) [8,11,12].
Nutrient–hormone interactions contributing to weight gain is still a
matter of discussion. In this context it has been suggested that ghrelin, a
peptide hormone with a 28-amino acid released from stomach, when
bound to the endogenous ligand for the growth hormone secretagogue
receptor (GHSR), is associated to weight gain [13], mainly by inducing
adiposity in humans and rodents [14]. In addition, despite the
controversial data describing that ghrelin increases abdominal adiposity
by a mechanism independent of its central orexigenic activity [13], the
fact that ghrelin and the receptor (GHSR) are present not only in tissues
such as stomach and intestine, but also in the central nervous system of
mammals (hypothalamus), suggests an integrative role of the hormone
on linking central and peripheral systems on modulation of energy
7V.M. Soares et al. / Regulatory Peptides 174 (2012) 6–11store and expenditure. Recent studies have shown that acylated ghrelin is
central to body fat mass control [13], storage [15], and oxidation of fatty
acids in white adipose tissue (WAT) via GHSR1a [4,16]. Furthermore,
these actions are directly associated to energy homeostasis, taking part
in metabolic control, such as insulin secretion and glucose uptake [3]
meaning that impairment of ghrelin action is also associated with the
onset of type 2 diabetes.
In this paper we hypothesized that in adipocytes ghrelin signaling
should be associated to fatty acid accumulation and an increase in
adiposity in the long term [5]. In other words, in obesity the direct
effect of ghrelin on glucose uptake stimulated by insulin should be
enhanced by increasing the GHSR1a/PI3K/AKT pathway [3,5,17].
Therefore, we studied the mechanisms by which ghrelin signaling
pathway contributes to WAT gain in obese pups that were overfed
during lactation. In these animals we studied key proteins involved on
ghrelin mediated action in WAT: GHSR 1a, PI3K/AKT/GLUT4 (glucose
uptake), 5′-AMP-activated protein kinase (AMPK) (energymetabolism),
CPT-1 (carnitine palmitoyltransferase I) (lipid oxidation), and PPARγ
(peroxisome proliferator-activated receptor-γ) (adipogenesis).
Mainly, our results demonstrated the rapid association between
quantitative changes of nutrients and obesity development in early
life. We also showed that the fattening process is directly associated
with altered ghrelin/GHSR1a system in WAT.2. Material and methods
2.1. Animals and treatments
Virgin female Swiss mice were time crossed at 3 months of age.
During pregnancy, theywere singly housed under standard conditions
with water and standard laboratory chow ad libitum. After birth,
litters were adjusted to nine pups per dam. At postnatal day 3, to
induce early postnatal overnutrition, the number of pups per
dam was adjusted to three male mice per litter to form the overfed
group (OG) [18], whereas litters containing nine pups per dam
served as control group (CG). In each litter, only one male offspring
was used to complete sample size. This is statistically and methodo-
logically important in order to discard pups of the same family [19].
Onlymale Swissmice were used in the present study for both groups.
They were weighed periodically and were killed at two different
moments, when they reached 21 and 90 days of age. After weaning
at postnatal day 21, mice were housed with three mice per cage
with free access to water and standard chow in a temperature-
controlled room with a 12 h light:12 h darkness cycle. They were
cared for in accordance with the Animal Care and Use Committee
of the Biology Institute of the State University of Rio de Janeiro,
which based its analysis on the principles described in the Guide
for Care and Use of Laboratory Animals [20].2.2. Blood collection
After a 4-h fast, blood glucose concentration was measured from
blood droplets removed from the tail vein of 21 day old OG and
age-matched CG mice with a glucometer (Accu-Chek, Roche, Sao
Paulo, Brazil).
To analyze acylated ghrelin levels, blood sample was obtained
under anaesthesia by heart puncture. Acylated ghrelin levels were
determined in plasma using a commercial assay kit (Millipore, ELISA
Kit, rat/mouse ghrelin active). Blood was collected into a centrifuge
tube containing enough K3 EDTA to achieve a ﬁnal concentration of
1.735 mg/mL and treatedwith Pefabloc followed by immediate centri-
fugation (3000 rpm for 10 min at 4 °C). The plasma was transferred to
another vial. Plasma sampleswere acidiﬁedwith HCl to a ﬁnal concen-
tration of 0.05 N and stored at−20 °C until assayed.2.3. Visceral fat measurement
21 day old mice were fasted for 4 h, injected with heparin and
anesthetized with Avertin (0.3 g/kg body weight, via i.p. injection). Fat
deposits (retroperitoneal and epididymal) were completely removed
from both sides of the animal and weighed on an analytical balance.
The retroperitoneal fat pad was regarded as the distinct deposit around
each kidney along the lumbar muscles, and the epididymal fat pad
included adipose tissue surrounding the ureters, bladder, and
epididymis.
2.4. Estimation of liver weight
The volume of liver was determined according to the submersion
method in which the water displacement (in isotonic saline), the
organ volume (V) was recorded by weighing (W). As the isotonic
saline speciﬁc density (d) is 1.0048, the respective volumes were
obtained by V [organ] (cm³)=W (g)/d or simply V (10³cm³)≅W (g)
[21].
2.5. Immunoprecipitation
Adipose tissue was lysed in 20 mM Tris HCl (pH 7.5), 150 mM
NaCl, 5 mM EDTA, 10 mM NaF, 2 mM Na3VO4, 1% NP-40, 0.1% SDS
plus Complete EDTA-Free Protease Inhibitor cocktail tablets (Roche
Diagnostics, California, USA). Lysates (2 μg/μL) were incubated for
2 h at 4 °C under rotation with either polyclonal goat anti-GHSR-1a
antibody (1:200; Santa Cruz Biotechnology, Santa Cruz, CA). Then,
protein A/G agarose (20 μL/mg protein; Santa Cruz Biotechnology)
was added, and sampleswere incubated at 4 °C overnight. The content
of GHSR-1a and of associated proteins was analyzed by Western
blotting as described below.
2.6. Western blot analysis
Total protein content in cell extracts was determined by the BCA
method (BCATM Protein Assay Kit, Thermo Scientiﬁc, Rockford,
U.S.A.). Protein samples were solubilized in Laemmli sample buffer
[22] (Tris–HCl 50 mM; pH 6,8; SDS 1%; 2β-mercaptoetanol 5%; glycerol
10; de bromophenol blue 0,001%) for 3 min at 100 °C and frozen before
undergoing to SDS-PAGE. Equal quantities of protein (30 μg)were loaded
onto 8 or 12% polyacrylamide gels in the presence of SDS (SDS-PAGE)
along with pre-stained molecular weight standards (Full Range
Rainbow; Amersham Biosciences, UK Limited). After electrophoretic
separation, proteins were transferred to nitrocellulose membranes
(Hybond P; Amersham Biosciences, UK Limited). The membranes
were blocked with Tween–TBS (10% Tween 20) containing 5% nonfat
dry milk for 1 h and incubated with the appropriate antibodies
overnight. The following primary antibodies were used: rabbit
anti-Akt 1/2 (H-136, Sc-8312, 1:1000, Santa Cruz Biotechnology),
rabbit anti-phosphorylated-AKT 1/2/3 (Ser473, Sc-7985-R, 1:1000,
Santa Cruz Biotechnology, USA), GHS-R1a (C-18, Sc-10368,
1:1000, Santa Cruz Biotechnology, USA), rabbit anti-PI3K p85α (Z-8)
(1:1000, Santa Cruz Biotechnology, USA), AMPK (1:1000, Upstate
Biotechnology, USA), phosphorylated-AMPKα (Thr172, 1:000, Upstate
Biotechnology, USA), rabbit anti-CPT-1 (H-40, Sc-98834, 1:1000, Santa
Cruz Biotechnology, USA), mouse anti-PPARγ (E-8, Sc:7273, 1:1000,
Santa Cruz Biotechnology, USA), rabbit anti-GLUT4 (H-61, Sc-7938,
1:1000, Santa Cruz Biotechnology) and actin (A2066, 1:1000, Sigma-
Aldrich). The PVDF ﬁlters were then incubated with appropriate
secondary antibodies conjugated to biotin (Sc-2040, Sc-2042,
1:2000 or 1:3000 or 1:5000, Santa Cruz Biotechnology), followed
by 1-h incubationwith horseradish peroxidase-conjugated streptavidin
(1:2000 or 1:3000 or 1:5000; Invitrogen, Camarillo, USA). Immuno-
reactivity was visualized by enhanced chemiluminescence (ECL-Plus,
Amersham Biosciences, Pittsburgh, PA, USA) and subsequently
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8 V.M. Soares et al. / Regulatory Peptides 174 (2012) 6–11quantiﬁed by densitometry using Image J Software (NIH, Bethesda,
MD, USA).
2.7. Statistical analysis
Results are expressed as mean±S.E.M. The GraphPad Prism 5
program (GraphPad softwares, Inc., La Jolla, CA, USA) was used for
statistical analyses and graphics. Statistical signiﬁcance was deter-
mined by Student's t-test for unpaired, bilaterally distributed values
of equal variance. pb0.05 was considered statistically signiﬁcant.
3. Results
3.1. Effects of overnutrition during the neonatal suckling period in body
weight gain
The body weight of OG and CG Swiss mice from the day of birth to
21 days of age were measured. Animals were weighed periodically,
and our data demonstrated that the OGmice were signiﬁcantly heavier
when compared to the CG mice (pb0.0001) since the 10th day of life.
This difference was higher (pb0.0001) in all measured ages until
21 days, persisting at 90 days of age (adulthood) (pb0.0001) (Table 1).
3.2. Effects of overnutrition during the neonatal suckling period on
visceral fat weight
As a result of changes observed in total body weight, OG animals
with 21 days of life had markedly higher epididymal (7-fold) and
retroperitoneal (4-fold) fat weight than their counterparts
(pb0.0001) (Table 1). This increase in visceral fat content can be
seen in Fig. 1. This difference was maintained at 90 days of age,
both epididymal and retroperitoneal fat weight were higher in the
OG than CG groups (pb0.001) (Table 1).
3.3. Effects of overnutrition during the neonatal suckling period on liver
weight and blood glucose level
Table 1 also shows that OG group had higher blood glucose levels
when compared with CG animals at 21 and 90 days of life (pb0.001).
In relation to the liver weight, OG group presented heavier liver
weight (35%) than CG animals at 21 days of life (pb0.001).
3.4. Effects of overnutrition during the neonatal suckling period on
ghrelin active levels
To investigate circulating levels of acylated ghrelin, we measured
these after 4 h of fasting OG group presented signiﬁcantly decreased
plasmatic acylated ghrelin levels (47.31±15.61 pg/mL) compared
with CG mice (155.3±16.91 pg/mL) (pb0.05) (Table 1).
3.5. Overnutrition during the neonatal suckling period increases GHSR-1a,
PI3K, AKT and AMPK contents in WAT
We evaluated GHSR-1a, PI3K, AKT and AMPK content inWAT from
CG and OG groups at 21 days age. OG mice presented higher GHSR-1a
(Fig. 2A) (pb0.001), and also higher levels of PI3K (Fig. 2B), AKT
(Fig. 2C) and AMPK (Fig. 2E) associated with GHSR-1a when compared
to CG group (pb0.001). Furthermore, we observed higher content of
phosphorylated AKT (Fig. 2D) and AMPK (Fig. 2F) in WAT of OG mice
compared to their counterparts (pb0.001).
3.6. Effect of overnutrition during neonatal suckling period on GLUT4
content in WAT
As expected, increased phosphorylated AKT induced higher GLUT4
content (34%) in OG compared to CG groups (Fig. 3B) in WAT.
CG OG
Fig. 1. Ventral viewof thedissected fat pads (bar=10mm): CGgroup showingdiminished
retroperitoneal and genital fat pads, leaving the lumbar muscle (‡) uncovered. OG group
showing increased genital fat pads (thin arrow).
IP: GHS
A B     IP: GHSR 1a IP: GHS
IB: GHSR1a
D
IP: GHSR 1a
IB: AKT
IB: pAKT
E
Fig. 2. Analysis of ghrelin signaling in adipose tissue of CG and OG mice. Immunoprecipitat
with anti-PI3K antibody (B, upper panel), anti-AKT (C, upper panel) and anti-pAKT (D, lowe
The results of scanning densitometry were expressed as arbitrary units. Results are express
9V.M. Soares et al. / Regulatory Peptides 174 (2012) 6–113.7. Effect of overnutrition during the neonatal suckling period on PPAR
gamma content in WAT
Fig. 3A shows a signiﬁcant decrease of PPAR gamma content in
WAT of OG compared to CG (pb0.001).
3.8. Effect of overnutrition during the neonatal suckling period on CPT1
content in WAT
Overfed animals showed increased CPT-1 content (48.4%) in WAT
when compared with their counterparts (Fig. 3C).
4. Discussion
We showed in conformity with other authors that overnutrition
during neonatal suckling period causes obesity prospectively mainly
by increasing visceral fat from 10 days up 21 days of offspring postnatal
life. Also, we showed that the difference in body composition persists
into adulthood (90 days) [6,10,23]. Basically, these data reinforces the
hypothesis that early life overfeeding should be considered an important
inducing factor towards obesity setting process [7,8,10,11,18,23]. With
reference to plasma ghrelin levels, our data showed that obese overfed
pups have a decreased plasmatic acylated ghrelin levels in relation to
control group at 21 days of age This result is also in accordance with
others who have showed that circulating ghrelin levels are decreasedIP: GHSR 1a
R 1a
R 1a C IP: GHSR 1a
IB: AKTIB: PI3K
IB: AMPK
F
IB: pAMPK
IB: AMPK
ion was performed with anti-GHS-R1a antibody (A, upper panel), and immunoblotted
r panel) antibodies and anti-AMPK and anti-pAMPK antibodies (E and F, lower panel).
ed as mean±S.E.M., n=5 animals per group, *pb0.01 compared to CG group.
C
IB: CPT 1
IB: Actin
IB: GLUT4
IB: Actin
A IB: PPAR
IB: Actin
B
Fig. 3.Western blot analysis of total PPAR γ, GLUT-4 and CPT1 content in adipose tissue of CG and OGmice. Tissue extracts were immunoblotted with anti-PPARγ antibody (A upper
panel), anti-GLUT-4 antibody (B upper panel) and anti-CPT antibody (C upper panel) in CG and OG mices. Immunoblot was performed employing anti-Actin antibody as the loaded
protein (lower panels A, B and C). The results of scanning densitometry were expressed as arbitrary units. Results are expressed as mean±S.E.M., n=5 animals per group, *pb0.05
compared to CG.
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that have showed that weight gain induced by overfeeding decreases
plasma ghrelin levels in rats [26,27].
We demonstrated the presence of ghrelin receptor GHSR-1a in
epididymal fat conﬁrming previous studies of other authors [13]. In
addition, we also veriﬁed that obesity induced in early life increases
the epididymal fat GHSR-1a expression and changes activation of
downstream signals involved in ghrelin-mediated effects in this tissue.
Therefore, our results allow us to suggest that the increased GHSR-1a
content in WAT may result and/or be part of an adaptive process to
compensate decreased hormone levels. Thus, in addition to altered
levels of the hormone, we showed that changes in ghrelin signaling
pattern may be central for an adaptive response of the adipocytes.
Furthermore, the increased activation of GHSR-1a observed in these
obese animals should be followed by a corresponding increase in
proteins involved in hormone signaling to ensure the increased
sensitivity of the WAT.
We showed that the increased GHSR-1a in WAT of OG mice with
21 days of life was associated to a higher content of PI3K, AKT and
phosphoAKT. Moreover, we also observed higher GLUT4 content in
WAT of obese mice. Since previous studies demonstrated that the
activation of GHSR-1a, PI3K, AKT and GLUT4 pathway increases
adipocyte glucose uptake, and these effects might be expected to
result in fatty acid accumulation [5], our data conﬁrm the increase
in adiposity observed in this model in the young animal, that persists
in adulthood [6,10,23].
Our results also showed higher glucose levels in young OG mice,
despite higher GLUT4 content in WAT. Our suggestion is that the
increased glucose transport inWATmay represent an adaptive response
to changes exerted by ghrelin in the process of action and sensitivity to
insulin. Ghrelin plays a major role in regulating glucose homeostasis
through the modulation of insulin secretion and insulin sensitivity [28].
In such way, for instance, Lin and coworkers showed that ablation of
GHSR reduces adiposity and improves insulin sensitivity by regulating
fat metabolism in white and brown adipose tissues [29].
Increased GHSR-1a expression was also directly associated with
increased expression of AMPK/pAMPK and CPT1. AMPK stimulates
pathways which increase energy production (glucose transport, fatty
acid oxidation) and switches off pathways which consume energy (li-
pogenesis, protein synthesis, gluconeogenesis) [30]. Thus, our data are
consistent with other studies that show that AMPK, when activated,
limits fatty acid efﬂux from adipocytes and favors local fatty acid
oxidation, inducing increased epididymal WAT mass basically
from adipocyte enlargement probably due to reduced lipid export
[31].Different studies demonstrated that ghrelin has no action or
decreases CPT-1 RNAm expression, which is a rate-limiting step in
lipid oxidation [15,32]. Surprisingly, we demonstrated a signiﬁcantly
decreased CPT1 expression in WAT of obese mice. We suggest that
the difference of our results when compared to the other authors
may be due to distinct methodologies. For instance, central or
peripheral administration of exogenous ghrelin generates different
physiological response. Also we observed that PPARγ content is
reduced in WAT of OG mice. Peroxisome proliferator-activated
receptor-γ (PPARγ) is known to be a key regulator of important
transcriptional pathways for adipogenesis. Other studies demonstrated
that ghrelin acts directly on adipocytes to stimulate differentiation from
preadipocytes and to antagonize lipolysis [33,34]. However, indirect
evidence suggests that AMPK activation can inhibit preadipocyte
differentiation and blocks the expression of late adipogenic
markers such as fatty acid synthase and the transcription factors
PPARγ and C/EBPα [35,36].
5. Conclusion
In summary, our data provide evidence that obesity caused by
overnutrition during lactation reduces circulating ghrelin acilated
levels and positively modulates ghrelin receptor signaling in white
adipose tissue, thus promoting weight gain and affecting energy
balance and glucose homeostasis in young mice.
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